Soc. Generale Call 90 AZN 20.12.2.../ DE000SU9A8Y8 /
2024-06-04 9:46:20 PM | Chg.+0.070 | Bid9:59:39 PM | Ask9:59:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.260EUR | +1.67% | 4.280 Bid Size: 800 |
4.550 Ask Size: 800 |
Astrazeneca PLC ORD ... | 90.00 GBP | 2024-12-20 | Call |
GlobeNewswire
06-04
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
GlobeNewswire
06-04
Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Effica...
GlobeNewswire
06-04
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...